Duriye Ozturk

8PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersRadiation therapyTumour immunologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2026
The HARP (Hemoglobin-Albumin-C-Reactive Protein) Index: A Biologically Designed Composite Biomarker for Continuous Prognostic Modeling in Locally Advanced Nasopharyngeal Carcinoma.

|Dec 08, 2025
A higher number of chemotherapy cycles given during and after radiation is linked to increased rates of radiation-induced trismus in locally advanced nasopharyngeal cancer patients.

Efsun Somay, Erkan Topkan, Sibel Bascil

|Oct 08, 2024
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.

Efsun Somay, Busra Yilmaz, Erkan Topkan

|Sep 21, 2024
The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol.

Erkan Topkan, Nilufer Kilic Durankus, Sukran Senyurek

|Jul 08, 2024
Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.

Erkan Topkan, Ahmet Kucuk, Duriye Ozturk

|Jul 05, 2023
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer.

Ahmet Kucuk, Erkan Topkan, Emine Elif Ozkan

Pageof 2

Frequent Collaborators

8 joint publications

Erkan Topkan

4 joint publications

Ugur Selek

4 joint publications

Efsun Somay

1 joint publications

Ahmet Kucuk